Multiparametric MRI for Assessing Breast Cancer Response to Anti-HER2 Therapy
- Status
- TERMINATED
- Phase
- N/A
Clinical Trials Related to HER2-positive Breast Cancer
Related studies linked through entity extraction aliases.
Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Capecitabine in HER-2 Positive Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of 68Ga-ABY-025 PET for Non-invasive Quantification of HER2-expression in Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- NA
PRS-343 in Combination With Atezolizumab in HER2-Positive Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH)
- Status
- COMPLETED
- Phase
- PHASE2
Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1
- Status
- TERMINATED
- Phase
- PHASE2
The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane.
- Status
- TERMINATED
- Phase
- NA
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Neoadjuvant Study of Pyrotinib in Combination With Trastuzumab in Patients With HER2 Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer
- Status
- UNKNOWN
- Phase
- N/A
A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Omission of Radiation in Patients With Her-2 Positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2